INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,655 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
BR
Boscolo RodrigoDirector
IZEAIZEA Worldwide, Inc.
Grant or award · 10b5-1 plan
A—
4,274 sh
Mar 31, 2026Apr 1, 2026
Page 1038 of 1742
← PrevNext →
traded Mar 31, 2026
+1d
SEC Form 4

Evidence

1
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$628K
74.4K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

1
PA
Pena Fernando AustinDirector, President
BXMTBLACKSTONE MORTGAGE TRUST, INC.
Open-market sale · 10b5-1 plan
SELL$31K
1,666 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

1
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$261K
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,500 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

0
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Option exercise · 10b5-1 plan
M—
120.0K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

0
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Derivative conversion · 10b5-1 plan
C—
11.00M sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

0
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
74.4K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

51
CE
Carter Charles EdwardChief Regional Officer: Amer.
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$114K
10.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

50
MR
Morgan RachelEVP General Counsel
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$668K
3,127 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

50
WS
Weaver Robert S.EVP, Government Relations
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$399K
1,872 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

47
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$434K
2,161 sh
Mar 6, 2026Mar 31, 2026
traded Mar 6, 2026
+25dSEC Form 4

Evidence

47
YF
Yeap Choh FeiSVP
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Open-market purchase
BUY$56K
1,000 sh
Mar 22, 2026Mar 31, 2026
traded Mar 22, 2026
+9dSEC Form 4

Evidence

46
LS
Lin Shyue-ShyhVP
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Open-market purchase
BUY$164K
3,000 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

44
DD
Degner DennisChief Executive Officer & Pres
RRCRANGE RESOURCES CORP
Open-market sale
SELL$693K
15.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

43
DM
de la Fuente MarianaHR Director
PAMPampa Energy Inc.
Grant or award
A$1.59B
21.6K sh
Mar 10, 2026Mar 31, 2026
traded Mar 10, 2026
+21dSEC Form 4

Evidence

41
MM
Marks Nataly MichelleDirector
MSIFMSC INCOME FUND, INC.
Open-market purchase
BUY$13K
1,000 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

40
PM
Preston Tracy MEVP, CLO & Corporate Secretary
MMacy's, Inc.
Open-market sale
SELL$49K
2,736 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

39
WG
Weitman GarySee Remarks
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$214K
1,005 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

39
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Open-market sale
SELL$54K
3,051 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

38
EH
Employees' Retirement System of the State of Hawaii10% Owner
NANALafayette Square USA, Inc.
Open-market purchase
BUY$4.00M
270.6K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

37
SJ
Stenberg JonDirector, President & CEO
CIACITIZENS, INC.
Open-market purchase
BUY$235K
50.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

37
VE
Vanzura ElisabethDirector, CMO
SBDSSolo Brands, Inc.
Open-market purchase
BUY$5,655
1,500 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

36
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Open-market purchase
BUY$99K
16.7K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

36
MW
McDowell Erin WSVP & General Counsel
RRCRANGE RESOURCES CORP
Open-market sale
SELL$396K
8,250 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

35
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$69K
1,252 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

35
SS
Szabo ShandellDirector
MGYMagnolia Oil & Gas Corp
Open-market sale
SELL$375K
11.7K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

33
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$146K
4,864 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

33
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$128K
4,256 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

33
EK
Eleftheriou KaterinaDirector
CMDBCostamare Bulkers Holdings Ltd
Open-market purchase
BUY$982
65 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

32
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$17K
313 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

32
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,991
74 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

32
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Open-market purchase
BUY$98K
19.1K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

30
GD
Garagic DenisCHIEF TECHNOLOGY OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$84K
15.1K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

29
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$356K
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

29
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$57K
1,838 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

29
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$65K
2,100 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

27
TT
Thatcher TrevorCHIEF FINANCIAL OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$17K
3,030 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence